Marksans Pharma - Quaterly Results

11 Feb 2022 Evaluate
Revenue showed a marginal decline at Rs. 1659.37 millions. For the quarter ended December 2021, as compared to corresponding quarter of last year.Net profit declined -10.46% to Rs. 260.57 millions from Rs. 291.02 millions.The company reported a degrowth in operating Profit to 398.85 millions from 411.23 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 1659.37 1684.55 -1.49 4820.11 4619.66 4.34 5995.48 4334.15 38.33
Other Income 120.65 62.41 93.32 346.03 192.47 79.78 311.56 1.73 17909.25
PBIDT 398.85 411.23 -3.01 1214.49 1061.79 14.38 1448.68 716.63 102.15
Interest 6.85 10.98 -37.61 25.17 32.07 -21.52 53.45 72.92 -26.70
PBDT 392.00 400.25 -2.06 1189.32 1029.72 15.50 1395.23 643.71 116.75
Depreciation 45.21 40.34 12.07 130.54 110.48 18.16 151.93 116.44 30.48
PBT 346.79 359.91 -3.65 1058.78 919.24 15.18 1243.30 527.27 135.80
TAX 86.22 68.89 25.16 233.18 172.32 35.32 259.49 148.24 75.05
Deferred Tax 1.22 -10.10 -112.08 16.30 -32.97 -149.44 -22.39 36.77 -160.89
PAT 260.57 291.02 -10.46 825.60 746.92 10.53 983.81 379.03 159.56
Equity 409.31 409.31 0.00 409.31 409.31 0.00 409.31 409.31 0.00
PBIDTM(%) 24.04 24.41 -1.54 25.20 22.98 9.62 24.16 16.53 46.14

Marksans Pharma Share Price

161.05 -2.05 (-1.26%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×